Using discrete choice experiments to investigate subject preferences for preventive asthma medication

被引:52
|
作者
Lancsar, Emily J.
Hall, Jane P.
King, Madeleine
Kenny, Patricia
Louviere, Jordan J.
Fiebig, Denzil G.
Hossain, Ishrat
Thien, Francis C. K.
Reddel, Helen K.
Jenkins, Christine R.
机构
[1] Univ Sydney, Cooperat Res Ctr Asthma, Sydney, NSW 2006, Australia
[2] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2007, Australia
[3] Univ Technol Sydney, Sch Mkt, Sydney, NSW 2007, Australia
[4] Univ New S Wales, Sch Econ, Sydney, NSW, Australia
[5] Woolcock Inst Med Res, Camperdown, NSW, Australia
[6] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia
[7] Monash Univ, Melbourne, Vic 3004, Australia
[8] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[9] Newcastle Univ, Business Sch Econ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
asthma; discrete choice experiment; patient preference; willingness to pay;
D O I
10.1111/j.1440-1843.2006.01005.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: Long-term adherence to inhaled corticosteroids is poor despite the crucial role of preventer medications in achieving good asthma outcomes. This study was undertaken to explore patient preferences in relation to their current inhaled corticosteroid medication, a hypothetical preventer or no medication. Methods: A discrete choice experiment was conducted in 57 adults with mild-moderate asthma and airway hyper-responsiveness, who were using inhaled corticosteroid <= 500 mu g/day (beclomethasone equivalent). In the discrete choice experiment, subjects evaluated 16 hypothetical scenarios made up of 10 attributes that described the process and outcomes of taking asthma medication, with two to four levels for each attribute. For each scenario, subjects chose between the hypothetical medication, the medication they were currently taking and no asthma medication. A random parameter multinomial logit model was estimated to quantify subject preferences for the aspects of taking asthma medication and the influence of attributes on medication decisions. Results: Subjects consistently made choices in favour of being able to do strenuous and sporting activities with or without reliever, experiencing no side-effects and never having to monitor their peak flow. Frequency of collecting prescriptions, frequency of taking the medication, its route of administration and the strength of the doctor recommendation about the medication were not significant determinants of choice. Conclusions: The results of this study suggest that patients prefer a preventer that confers capacity to maximize physical activity, has no side-effects and does not require daily peak flow monitoring.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 50 条
  • [1] Using discrete choice experiment to investigate patients' and parents' preferences for initiating ADHD medication
    Khan, Muhammad Umair
    Balbontin, Camila
    Bliemer, Michiel
    Aslani, Parisa
    [J]. JOURNAL OF MENTAL HEALTH, 2023, 32 (02) : 373 - 385
  • [2] Using Discrete Choice Experiments to Quantify Patient Preferences
    O'Hara, Nathan N.
    Sciadini, Marcus F.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2024, 32 (01) : 8 - E16
  • [3] Estimating time preferences for health using discrete choice experiments
    van der Pol, M
    Cairns, J
    [J]. SOCIAL SCIENCE & MEDICINE, 2001, 52 (09) : 1459 - 1470
  • [4] Using discrete choice experiments to value preferences for pharmacy services
    Payne, Katherine
    Elliott, Rachel
    [J]. INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2005, 13 (01) : 9 - 20
  • [5] Use of discrete choice experiments to elicit preferences
    Ryan, M
    Bate, A
    Eastmond, CJ
    Ludbrook, A
    [J]. QUALITY IN HEALTH CARE, 2001, 10 : I55 - I60
  • [6] Segmenting Patients and Physicians Using Preferences from Discrete Choice Experiments
    Deal, Ken
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2014, 7 (01): : 5 - 21
  • [7] Segmenting Patients and Physicians Using Preferences from Discrete Choice Experiments
    Ken Deal
    [J]. The Patient - Patient-Centered Outcomes Research, 2014, 7 : 5 - 21
  • [8] Using discrete choice experiments to define patient preferences for outcomes in trials
    Emily Fargher
    Dyfrig Hughes
    Adele Ring
    Ann Jacoby
    Margaret Rawnsley
    Anthony Marson
    [J]. Trials, 14 (Suppl 1)
  • [9] Using discrete choice experiments to value preferences for a clinical genetic service
    Payne, K
    McAllister, M
    Middleton-Price, H
    Donnai, D
    Davies, LM
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 : S46 - S46
  • [10] Understanding the Treatment Preferences of Neuroendocrine Tumor Patients Using Discrete Choice Experiments
    Anaka, Matthew
    Chan, David
    Pattison, Sharon
    Thawer, Alia
    Franco, Bryan
    Moody, Lesley
    Jackson, Christopher
    Segelov, Eva
    Singh, Simron
    [J]. PANCREAS, 2020, 49 (03) : 462 - 462